NCT07146737 Predictive Performance of a Generative Model for Corneal Tomography After ICL Implantation
| NCT ID | NCT07146737 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital of Nanchang University |
| Condition | ICL |
| Study Type | OBSERVATIONAL |
| Enrollment | 818 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2025-07-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 818 participants in total. It began in 2025-07-01 with a primary completion date of 2025-07-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the efficacy of a corneal tomography Imaging model in predicting postoperative vault based on preoperative corneal topography in Implantable Collamer Lens (ICL) surgery.
Eligibility Criteria
Inclusion Criteria:(1) stable myopia (≤0.50D/year change for 2 years), (2) ACD ≥2.80mm, (3) intact corneal endothelium (≥2000 cells/mm²), and (4) no confounding ocular/systemic conditions. Exclusion Criteria:(1) glaucoma-spectrum disorders or retinal vasculopathies, (2) prior corneal/intraocular surgery, (3) compromised corneal endothelium, (4) uncontrolled systemic diseases, and (5) pregnancy/lactation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07146737 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying ICL. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07146737 currently recruiting?
Yes, NCT07146737 is actively recruiting participants. Contact the research team at 564436578@qq.com for enrollment information.
Where is the NCT07146737 trial being conducted?
This trial is being conducted at Nanchang, China.
Who is sponsoring the NCT07146737 clinical trial?
NCT07146737 is sponsored by Second Affiliated Hospital of Nanchang University. The trial plans to enroll 818 participants.